PHARMACIE MARCHE VAILLANT : revenue, balance sheet and financial ratios

PHARMACIE MARCHE VAILLANT is a French company founded 24 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BOBIGNY (93000), this company of category PME shows in 2023 a revenue of 1.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE MARCHE VAILLANT (SIREN 440943421)
Indicator 2024 2023 2022 2020 2019 2018 2016
Revenue N/C 1 657 001 € 1 630 025 € 1 627 706 € 1 718 798 € 1 743 974 € 1 845 924 €
Net income -147 092 € 35 124 € 28 510 € 10 816 € -84 185 € -84 782 € 54 240 €
EBITDA N/C 46 518 € 27 933 € 14 427 € -25 668 € -75 087 € 68 760 €
Net margin N/C 2.1% 1.7% 0.7% -4.9% -4.9% 2.9%

Revenue and income statement

In 2024, PHARMACIE MARCHE VAILLANT records a net loss of 147 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-147 092 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 81%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 40%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

81.128%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

40.272%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

2.0%

Solvency indicators evolution
PHARMACIE MARCHE VAILLANT

Sector positioning

Debt ratio
81.13 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +13 pts over 3 years

In 2024, the debt ratio of PHARMACIE MARCHE VAILLANT (81.13) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
40.27% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -14 pts over 3 years

In 2024, the financial autonomy of PHARMACIE MARCHE VAILLANT (40.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
7.19 years 2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average

In 2023, the repayment capacity of PHARMACIE MARCHE VAILLANT (7.19) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 174.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

174.151

Liquidity indicators evolution
PHARMACIE MARCHE VAILLANT

Sector positioning

Liquidity ratio
174.15 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average -11 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE MARCHE VAILLANT (174.15) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average

In 2023, the interest coverage of PHARMACIE MARCHE VAILLANT (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE MARCHE VAILLANT

Positioning of PHARMACIE MARCHE VAILLANT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE MARCHE VAILLANT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE MARCHE VAILLANT

What is the revenue of PHARMACIE MARCHE VAILLANT ?

The revenue of PHARMACIE MARCHE VAILLANT in 2023 is 1.7 M€.

Is PHARMACIE MARCHE VAILLANT profitable?

PHARMACIE MARCHE VAILLANT recorded a net loss in 2024.

Where is the headquarters of PHARMACIE MARCHE VAILLANT ?

The headquarters of PHARMACIE MARCHE VAILLANT is located in BOBIGNY (93000), in the department Seine-Saint-Denis.

Where to find the tax return of PHARMACIE MARCHE VAILLANT ?

The tax return of PHARMACIE MARCHE VAILLANT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE MARCHE VAILLANT operate?

PHARMACIE MARCHE VAILLANT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.